A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants
Clinical trial NCT05602025 · COMPLETED
Trial details
- NCT number
- NCT05602025
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2023-10-23
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.